Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Segment R&D Expense by Year
Segment R&D Expense — ASU 2023-07 — Laboratory Products & Biopharma Services ($M)
Thermo Fisher Scientific Segment R&D Expense: $56M in FY2025, down 15.2% from a year earlier.
Where the FY2025 figure comes from
“|| Research and development expenses | 553 | 573 | 178 | 56”
Source: SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Reported in SEC 10-K / 10-Q Note 11 (ASU 2023-07 Segment Disaggregation).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Segment R&D Expense — ASU 2023-07 — Laboratory Products & Biopharma Services ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56 | -15.2% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 66 | -2.9% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 68 | -20.0% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 85 | – | SEC Form 10-K (10k_2024, filed 2025-02-20) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Segment R&D Expense ($M), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-rd-lpbs
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.